초록
Provided is a method for therapy of a pulmonary disease, the method comprising administering to an individual a composition in an amount effective to inhibit pulmonary inflammation, wherein the composition comprises an extract of Gynostemma pentaphyllum, an extract of Crataegus pinnatifida, and an extract of Camellia sinensis.
Provided is a method for therapy of a pulmonary disease, the method comprising administering to an individual a composition in an amount effective to inhibit pulmonary inflammation, wherein the composition comprises an extract of Gynostemma pentaphyllum, an extract of Crataegus pinnatifida, and an extract of Camellia sinensis.
대표
청구항
▼
Provided is a method for therapy of a pulmonary disease, the method comprising administering to an individual a composition in an amount effective to inhibit pulmonary inflammation, wherein the composition comprises an extract of Gynostemma pentaphyllum, an extract of Crataegus pinnatifida, and an extract of Camellia sinensis. enyl)-2,2-dimethyl-cyclopropane carboxylate (cypermethrin); beta-cypermethrin; theta cypermethrin; S-cyano (3-phenoxyphenyl)methyl (±) cis/trans 3-(2,2-dichloroethenyl) 2,2 dimethylcyclopropane carboxylate (zeta-cypermethrin); (s)-...
Provided is a method for therapy of a pulmonary disease, the method comprising administering to an individual a composition in an amount effective to inhibit pulmonary inflammation, wherein the composition comprises an extract of Gynostemma pentaphyllum, an extract of Crataegus pinnatifida, and an extract of Camellia sinensis. enyl)-2,2-dimethyl-cyclopropane carboxylate (cypermethrin); beta-cypermethrin; theta cypermethrin; S-cyano (3-phenoxyphenyl)methyl (±) cis/trans 3-(2,2-dichloroethenyl) 2,2 dimethylcyclopropane carboxylate (zeta-cypermethrin); (s)-alpha-cyano-3-phenoxybenzyl (IR,3R)-3-(2,2-dibromovinyl)-2,2-dimethyl cyclopropanecarboxylate (deltamethrin); alpha-cyano-3-phenoxybenzyl 2,2,3,3,-tetramethyl cyclopropoanecarboxylate (fenpropathrin); (RS)-alpha-cyano-3-phenoxybenzyl (R)-2-[2-chloro-4-(trifluoromethyl)anilino]-3-methylbutanoate (tau-fluvalinate); (±)-cyano (3-phenoxyphenyl)methyl (±)-4-(difluoromethoxy)-alpha-(1-methyl ethyl)benzeneacetate (flucythrinate); cyano(4-fluoro-3-phenoxyphenyl)methyl 3-[2-chloro-2-(4-chlorophenyl)ethenyl]-2,2-dimethylcyclopropanecarboxylate (flumeth rin); cyano(4-fluoro-3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethyl-cyclopropanedarboxylate (cyfluthrin); beta cyfluthrin; transfluthrin; (S)-alpha-cyano-3-phenoxybenzyl (Z)-(IR-cis)-2,2-dimethyl-3-[2-(2,2,2-trifluoro-trifluoromethyl-ethoxycarbonyl)vinyl]cyclopropane carboxylate (acrinathrin); (IR cis) S and (IS cis) R enantiomer isomer pair of alpha-cyano-3-phenoxybenzyl-3-(2,2dichlorovinyl)-2,2-dimethylcyclopropane carboxylate (alphacypermethrin); [IR,3S)3(1'RS)(1',2',2',2'-tetrabromoethyl)]-2,2-dimethyl cyclopropanecarboxylic acid (s)-alpha-cyano-3-phenoxybenzyl ester (tralomethrin); cyano-(3-phenoxyphenyl)methyl 2,2-dichloro-1-(4-ethoxyphenyl)cyclopropane carboxylate (cycloprothrin); [1α, 3α(Z)]-(±)-cyano-(3-phenoxyphenyl)methyl 3-(2-chloro-3,3,3-trifluoro-1-propenyl)-2,2-cimethylcyclopropanecarboxylate (cyhalothrin); [1 alpha (s), 3 alpha(z)]-cyano(3-phenoxyphenyl)methyl-3-(2-chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethylcyclopropane carboxylate (lambda cyhalothrin); (2-methyl [1,1'-biphenyl]-3-yl)methyl 3-(2-chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethyl-cyclopropanecarboxylate (bifenthrin); 5-1-benzyl-3-furylmethyl-d-cis(1R,3S, E)2,2-dimethyl-3-(2-oxo,-2,2,4,5 tetrahydro thiophenylidenemethyl)cyclopropane carboxylate (kadethrin, RU15525); [5-(phenyl methyl)-3-furanyl]-3-furanyl 2,2-dimethyl-3-(2-methyl-1-propenyl)cyclopropane carboxylate (resmethrin); (1R-trans)-[5-(phenylmethyl)-3-furanyl]methyl 2,2-dimethyl-3-(2-methyl-1-propenyl)cyclopropanecarboxylate (bioresmethrin); 3,4,5,6-tetra hydro-phthalimidomethyl-(IRS)-cis-trans-chrysanthemate (tetramethrin); 3-phenoxybenzyl-d,l-cis,trans 2,2-dimethyl-3-(2-methylpropenyl)cyclopropane carboxylate (phenothrin); cyphenothrin; prallethrin; imiprothrin; (RS)-3-allyl-2-methyl-4-oxcyclopent-2-enyl-(1A,3R; 1R,3S)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane carboxylate (allethrin); ZXI 8901; and mixtures thereof. 16. The method as set forth in claim 14, wherein the synthetic pyrethroid is selected from the group consisting of lambda cyhalothrin, bifenthrin, permethrin and cyfluthrin. 17. The method as set forth in claim 14, wherein the synthetic pyrethroid is lambda cyhalothrin. 18. A method of protecting a transgenic plant against damage by multiple pests, the method comprising treating a seed from which the transgenic plant grows, which seed has at least one heterologous gene encoding for the expression of a protein that is active against a first pest, with a composition comprising at least one pyrethrin or pyrethroid which is selected on the basis of its activity in preventing damage to the shoots and foliage of the plant by an insect that is different from the first pest and which has a vapor pressure of less than 6 mPa at 20° C. in an amount of at least 88 grams per 100 kilograms of the seed, and wherein the seed is selected from the group consisting of corn, soybean, cotton, rice, sorghum, wheat, barley, rye, sunflower, tomato, sugarcane, tobacco, rape and oats. 19. The method as set forth in claim 18, wherein the pyrethrin or pyrethroid is a water-insoluble, non-volatile pesticide. 20. The method as set forth in claim 18, wherein the pyrethrin or pyrethroid is one having a water solub
